Literature DB >> 25751839

Femtosecond laser-assisted cataract surgery after implantation of a transparent near vision corneal inlay.

Gregory D Parkhurst, Enrique Barragan Garza, Arthur A Medina.   

Abstract

PURPOSE: To describe two cases of successful femtosecond laser-assisted cataract surgery in patients with a transparent hydrogel corneal inlay (Raindrop Near Vision Inlay; ReVision Optics, Inc., Lake Forest, CA).
METHODS: Case report.
RESULTS: In both cases, femtosecond laser-assisted cataract surgery was performed with the inlay in place. The femtosecond laser pulses were delivered without difficulties, and the Raindrop inlay did not interfere with the visualization of intraocular structures during surgery. Following implantation of a monofocal intraocular lens targeted for plano, both patients experienced improvements in their uncorrected distance visual acuity and regained near vision.
CONCLUSIONS: These two cases suggest that the presence of the Raindrop inlay left in situ does not preclude successful femtosecond laser-assisted cataract surgery. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751839     DOI: 10.3928/1081597X-20150224-05

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

Review 1.  Refractive corneal inlay implantation outcomes: a preliminary systematic review.

Authors:  José-María Sánchez-González; Davide Borroni; Rahul Rachwani-Anil; Carlos Rocha-de-Lossada
Journal:  Int Ophthalmol       Date:  2021-10-02       Impact factor: 2.031

Review 2.  Small-aperture intracorneal inlay implantation in emmetropic presbyopic patients: a systematic review.

Authors:  Inés Pluma-Jaramago; Carlos Rocha-de-Lossada; Rahul Rachwani-Anil; José-María Sánchez-González
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

Review 3.  Corneal-Based Surgical Presbyopic Therapies and Their Application in Pseudophakic Patients.

Authors:  Grace L Paley; Roy S Chuck; Linda M Tsai
Journal:  J Ophthalmol       Date:  2016-03-09       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.